Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18421-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18421-1-AP, RRID:AB_2278161
- Product name
- FAM84B antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated FAM84B antibody (Cat. #18421-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references FAM84B promotes breast cancer tumorigenesis through activation of the NF-κB and death receptor signaling pathways.
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis.
Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma.
An in vitro vesicle formation assay reveals cargo clients and factors that mediate vesicular trafficking.
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.
FAM84B promotes prostate tumorigenesis through a network alteration.
Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Upregulation of FAM84B during prostate cancer progression.
Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation.
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism.
Zhang Y, Yang F
Pathology, research and practice 2023 Sep;249:154785
Pathology, research and practice 2023 Sep;249:154785
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis.
Chen Y, Jie X, Xing B, Wu Z, Yang X, Rao X, Xu Y, Zhou D, Dong X, Zhang T, Yang K, Li Z, Wu G
Cell death & disease 2022 Feb 3;13(2):110
Cell death & disease 2022 Feb 3;13(2):110
Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma.
Wang F, Cheng C, Wang X, Chen F, Li H, Zhou Y, Wang Y, Hu X, Kong P, Zhang L, Cheng X, Cui Y
Cell death discovery 2022 Apr 8;8(1):182
Cell death discovery 2022 Apr 8;8(1):182
An in vitro vesicle formation assay reveals cargo clients and factors that mediate vesicular trafficking.
Huang Y, Yin H, Li B, Wu Q, Liu Y, Poljak K, Maldutyte J, Tang X, Wang M, Wu Z, Miller EA, Jiang L, Yao ZP, Guo Y
Proceedings of the National Academy of Sciences of the United States of America 2021 Aug 31;118(35)
Proceedings of the National Academy of Sciences of the United States of America 2021 Aug 31;118(35)
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway.
Zhang X, Xu J, Yan R, Zhang Y, Hu Z, Fu H, You Q, Cai Q, Yang D
Aging 2020 Apr 14;12(8):6808-6822
Aging 2020 Apr 14;12(8):6808-6822
FAM84B promotes prostate tumorigenesis through a network alteration.
Jiang Y, Lin X, Kapoor A, He L, Wei F, Gu Y, Mei W, Zhao K, Yang H, Tang D
Therapeutic advances in medical oncology 2019;11:1758835919846372
Therapeutic advances in medical oncology 2019;11:1758835919846372
Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression.
Zhang Y, Li Q, Yu S, Zhu C, Zhang Z, Cao H, Xu J
Biochemical and biophysical research communications 2019 Feb 12;509(3):753-762
Biochemical and biophysical research communications 2019 Feb 12;509(3):753-762
Upregulation of FAM84B during prostate cancer progression.
Wong N, Gu Y, Kapoor A, Lin X, Ojo D, Wei F, Yan J, de Melo J, Major P, Wood G, Aziz T, Cutz JC, Bonert M, Patterson AJ, Tang D
Oncotarget 2017 Mar 21;8(12):19218-19235
Oncotarget 2017 Mar 21;8(12):19218-19235
Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.
Cheng C, Cui H, Zhang L, Jia Z, Song B, Wang F, Li Y, Liu J, Kong P, Shi R, Bi Y, Yang B, Wang J, Zhao Z, Zhang Y, Hu X, Yang J, He C, Zhao Z, Wang J, Xi Y, Xu E, Li G, Guo S, Chen Y, Yang X, Chen X, Liang J, Guo J, Cheng X, Wang C, Zhan Q, Cui Y
GigaScience 2016;5:1
GigaScience 2016;5:1
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant Chemoradiation.
Hsu FM, Cheng JC, Chang YL, Lee JM, Koong AC, Chuang EY
Scientific reports 2015 May 18;5:10291
Scientific reports 2015 May 18;5:10291
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism.
Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X, Ding W, Yu L, Wang X, Wang L, Shen H, Zhang C, Liu H, Liu X, Zhao Y, Fang X, Li S, Chen W, Tang T, Fu A, Wang Z, Chen G, Gao Q, Li S, Xi L, Wang C, Liao S, Ma X, Wu P, Li K, Wang S, Zhou J, Wang J, Xu X, Wang H, Ma D
Nature genetics 2015 Feb;47(2):158-63
Nature genetics 2015 Feb;47(2):158-63
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 18421-1-AP(FAM84B antibody) at dilution of 1:400
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FAM84B antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human FAM84B. This antibody recognizes human antigen. The FAM84B antibody has been validated for the following applications: ELISA, WB, IHC analysis.
